Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --other
|  
|
aberrant expression of VENTX in normal CD34+ progenitor cells perturbs normal hematopoietic development, promoting generation of myeloid cells and impairing generation of lymphoid cells | tumoral
|  
|  
| --other
|  
|
aberrantly expressed in malignant myeloid cells with particularly high expression in AML cases with t(8;21) or normal karyotype | tumoral
|  
|  
| --low
|  
|
in chronic lymphocytic leukemia | tumoral
|  
|  
| --other
|  
|
altered expression associated with corresponding changes of LEF1 target oncogenes such as CCND1, suggesting a potential role of VENTX in the clinical behavior of hematopoietic malignancies | |